Francesca Ferrante is an experienced pharmaceutical executive currently serving as VP and Head of Clinical Development and Regulatory Affairs at Spur Therapeutics since December 2021. Prior to this role, Francesca held multiple leadership positions at Bayer Pharmaceuticals, including Global Clinical Leader for Rare Diseases and Cell & Gene Therapy as well as for Haematology from January 2017 to December 2021. Francesca's expertise in hemophilia and clinical development was further demonstrated during tenures at Swedish Orphan Biovitrum AB (Sobi), where Francesca served as Medical Director and Associate Director of Clinical and Medical Sciences. Additional roles include Medical Science Manager at Sobi, Medical Advisor at LEO Pharma, and Medical Manager at Novo Nordisk, reflections of a robust career in the pharmaceutical industry spanning over a decade.
This person is not in any teams
This person is not in any offices